Published Date: 08 Mar 2023
A study presented at the American College of Cardiology Annual Review showed that a wrist-worn test predicted troponin-I and occluded arteries with 90% accuracy within 5 minutes.
Read Full NewsFormer UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and tackle health inequalities ...
In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...
About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a standard mammogram. Having dense breast tissue can make it harder to detect cancer and sometimes leads ...
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.
1.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
2.
Beyond What Is Visible in Myelofibrosis?
3.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
4.
Integrative palliative care is critical to improving mental health among pancreatic cancer patients
5.
Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation
1.
Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma
2.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
3.
Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation